Liver X receptor up-regulates α-tocopherol transfer protein expression and α-tocopherol status

Journal of Nutritional Biochemistry

Volumn 24, Issue 12, 2013, Pages 2158-2167

  Koh, Maki ^a   Takitani, Kimitaka ^a   Miyazaki, Hiroshi ^a   Yamaoka, Shigeo ^a   Tamai, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Tocopherol; Tocopherol transfer protein ( TTP); Lipogenesis; Liver X receptor (LXR)

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL CARRIER PROTEIN; CARRIER PROTEIN; LIVER X RECEPTOR; RETINOID X RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CHOLESTEROL METABOLISM; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; HUMAN; LIPOGENESIS; LIVER CELL; MALE; NONHUMAN; OXIDATIVE STRESS; POINT MUTATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

LIPOGENESIS; LIVER X RECEPTOR (LXR); Α-TOCOPHEROL; Α-TOCOPHEROL TRANSFER PROTEIN (Α-TTP);

ALPHA-TOCOPHEROL; ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; HUMANS; HYDROCARBONS, FLUORINATED; LIPOGENESIS; LIVER; MALE; ORPHAN NUCLEAR RECEPTORS; PROMOTER REGIONS, GENETIC; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SULFONAMIDES; UP-REGULATION; VITAMIN E DEFICIENCY;

EID: 84887541408     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.008     Document Type: Article

References (51)

1. Devaraj S., Leonard S., Traber M.G., Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008, 44:1203-1208.
2. Mustacich D.J., Bruno R.S., Traber M.G. Vitamin E. Vitam Horm 2007, 76:1-21.
3. Manor D., Morley S. The α-tocopherol transfer protein. Vitam Horm 2007, 76:45-65.
4. Jishage K., Arita M., Igarashi K., Iwata T., Watanabe M., Ogawa M., et al. α-Tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem 2001, 276:1669-1672.
5. Kaempf-Rotzoll D.E., Traber M.G., Arai H. Vitamin E and transfer proteins. Curr Opin Lipidol 2003, 14:249-254.
6. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., et al. Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci U S A 2001, 98:15185-15190.
7. Ouahchi K., Arita M., Kayden H., Hentati F., Ben Hamida M., Sokol R., et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat Genet 1995, 9:141-145.
8. Cavalier L., Ouahchi K., Kayden H.J., Di Donato S., Reutenauer L., Mandel J.L., et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998, 62:301-310.
9. Christopher Min K. Structure and function of α-tocopherol transfer protein: implications for vitamin E metabolism and AVED. Vitam Horm 2007, 76:23-43.
10. Kim H.S., Arai H., Arita M., Sato Y., Ogihara T., Inoue K., et al. Effect of α-tocopherol status on α-tocopherol transfer protein expression and its messenger RNA level in rat liver. Free Radic Res 1998, 28:87-92.
11. Shaw H.M., Cj Huang Liver α-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. J Nutr 1998, 128:2348-2354.
12. Fechner H., Schlame M., Guthmann F., Stevens P.A., Rüstow B. α- and δ-tocopherol induce expression of hepatic α-tocopherol-transfer-protein mRNA. Biochem J 1998, 331:577-581.
13. Ban R., Takitani K., Kim H.S., Murata T., Morinobu T., Ogihara T., et al. α-Tocopherol transfer protein expression in rat liver exposed to hyperoxia. Free Radic Res 2002, 36:933-938.
14. Bella D.L., Schock B.C., Lim Y., Leonard S.W., Berry C., Cross C.E., et al. Regulation of the α-tocopherol transfer protein in mice: lack of response to dietary vitamin E or oxidative stress. Lipids 2006, 41:105-112.
15. Chen W.H., Li Y.J., Wang M.S., Kang Z.C., Huang H.L., Shaw H.M. Elevation of tissue α-tocopherol levels by conjugated linoleic acid in C57BL/6J mice is not associated with changes in vitamin E absorption or α-carboxyethyl hydroxychroman production. Nutrition 2012, 28:59-66.
16. Ulatowski L., Dreussi C., Noy N., Barnholtz-Sloan J., Klein E., Manor D. Expression of the α-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic Biol Med 2012, 53:2318-2326.
17. Traber M.G. Vitamin E bioavailability. The encyclopedia of vitamin E 2007, 381-398. CABI, Wallingford. V.R. Preedy, R.R. Watson (Eds.).
18. Jakobsson T., Treuter E., Gustafsson J.Å., Steffensen K.R. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 2012, 33:394-404.
19. Chiang J.Y. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002, 23:443-463.
20. Zhao C., Dahlman-Wright K. Liver X, receptor in cholesterol metabolism. J Endocrinol 2010, 204:233-240.
21. Iwahori T., Matsuura T., Maehashi H., Sugo K., Saito M., Hosokawa M., et al. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 2003, 37:665-673.
22. Tamai H., Manago M., Yokota K., Kitagawa M., Mino M. Determination of α-tocopherol in buccal mucosal cells using an electrochemical detector. Int J Vitam Nutr Res 1988, 58:202-207.
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
25. Kato S., Tora L., Yamauchi J., Masushige S., Bellard M., Chambon P. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically. Cell 1992, 68:731-742.
26. Bełtowski J. Liver X, receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovasc Ther 2008, 26:297-316.
27. Etzl R.P., Vrekoussis T., Kuhn C., Schulze S., Pöschl J.M., Makrigiannakis A., et al. Oxidative stress stimulates α-tocopherol transfer protein in human trophoblast tumor cells BeWo. J Perinat Med 2012, 40:373-378.
28. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003, 17:985-993.
29. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006, 116:607-614.
30. Calkin A.C., Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 2012, 13:213-224.
31. Traber M.G., Goldberg I., Davidson E., Lagmay N., Kayden H.J. Vitamin E uptake by human intestinal cells during lipolysis in vitro. Gastroenterology 1990, 98:96-103.
32. Ecker J., Liebisch G., Patsch W., Schmitz G. The conjugated linoleic acid isomer trans-9, trans-11 is a dietary occurring agonist of liver X receptor α. Biochem Biophys Res Commun 2009, 388:660-666.
33. Saha S.S., Dasgupta P., Sengupta Bandyopadhyay S., Ghosh M. Synergistic effect of conjugated linolenic acid isomers against induced oxidative stress, inflammation and erythrocyte membrane disintegrity in rat model. Biochim Biophys Acta 1820, 2012:1951-1970.
34. Laffitte B.A., Joseph S.B., Walczak R., Pei L., Wilpitz D.C., Collins J.L., et al. Autoregulation of the human liver X receptor α promoter. Mol Cell Biol 2001, 21:7558-7568.
35. Fattoretti P., Bertoni-Freddari C. Cellular metabolism in vitamin E deficiency. The encyclopedia of vitamin E 2007, 327-338. CABI, Wallingford. V.R. Preedy, R.R. Watson (Eds.).
36. Violi F., Cangemi R., Sabatino G., Pignatelli P. Vitamin E for the treatment of cardiovascular disease: is there a future?. Ann N Y Acad Sci 2004, 1031:292-304.
37. Kontush K., Schekatolina S. Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann N Y Acad Sci 2004, 1031:249-262.
38. Manuel-Keenoy B. Vitamin E supplementation in diabetes mellitus. The encyclopedia of vitamin E 2007, 381-398. CABI, Wallingford. V.R. Preedy, R.R. Watson (Eds.).
39. Aye I.L., Waddell B.J., Mark P.J., Keelan J.A. Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-κB. Mol Hum Reprod 2012, 18:341-353.
40. Marcil V., Delvin E., Sané A.T., Tremblay A., Levy E. Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardiovasc Res 2006, 72:473-482.
41. Gao S., Han X., Fu J., Yuan X., Sun X., Li Q. Influence of chronic stress on the compositions of hepatic cholesterol and triglyceride in male Wistar rats fed a high fat diet. Hepatol Res 2012, 42:686-695.
42. Russo V. Metabolism, LXR/LXR ligands, and tumor immune escape. J Leukoc Biol 2011, 90:673-679.
43. Björkhem I., Araya Z., Rudling M., Angelin B., Einarsson C., Wikvall K. Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J Biol Chem 2002, 277:26804-26807.
44. Smith W.L., Murphy R.C. Oxidized lipids formed non-enzymatically by reactive oxygen species. J Biol Chem 2008, 283:15513-15514.
45. Arca M., Natoli S., Micheletta F., Riggi S., Di Angelantonio E., Montali A., et al. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med 2007, 42:698-705.
46. Alkazemi D., Egeland G., Vaya J., Meltzer S., Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab 2008, 93:4282-4289.
47. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., et al. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci U S A 1999, 96:266-271.
48. Morello F., Saglio E., Noghero A., Schiavone, Williams T.A., Verhovez A., et al. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 2009, 207:38-44.
49. Naito Y., Shimozawa M., Kuroda M., Nakabe N., Manabe H., Katada K., et al. Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 2005, 180:19-25.
50. Landrier J.F., Gouranton E., Reboul E., Cardinault N., El Yazidi C., Malezet-Desmoulins C., et al. Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. J Nutr Biochem 2010, 21:1207-1213.
51. Valastyan S., Thakur V., Johnson A., Kumar K., Manor D. Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis. Biochemistry 2008, 47:744-752.